Kumar B Pabbisetty

Years Active: 2020-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Andrew K Dilger, Kumar B Pabbisetty, James R Corte, Indawati De Lucca, Tianan Fang, Wu Yang, Donald J P Pinto, Yufeng Wang, Yeheng Zhu, Arvind Mathur, Jianqing Li, Xiaoping Hou, Daniel Smith, Dawn Sun, Huiping Zhang, Subramaniam Krishnananthan, Dauh-Rurng Wu, Joseph E Myers, Steven Sheriff, Karen A Rossi, Silvi Chacko, Joanna J Zheng, Michael A Galella, Theresa Ziemba, Elizabeth A Dierks, Jeffrey M Bozarth, Yiming Wu, Earl Crain, Pancras C Wong, Joseph M Luettgen, Ruth R Wexler, William R Ewing
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy. Journal of medicinal chemistry (2021)
Wu Yang, Yufeng Wang, Amy Lai, Charles G Clark, James R Corte, Tianan Fang, Paul J Gilligan, Yoon Jeon, Kumar B Pabbisetty, Richard A Rampulla, Arvind Mathur, Mahammed Kaspady, Premsai Rai Neithnadka, Arunachalam Arumugam, Sivashankaran Raju, Karen A Rossi, Joseph E Myers, Steven Sheriff, Zhen Lou, Joanna J Zheng, Silvi A Chacko, Jeffrey M Bozarth, Yiming Wu, Earl J Crain, Pancras C Wong, Dietmar A Seiffert, Joseph M Luettgen, Patrick Y S Lam, Ruth R Wexler, William R Ewing
Discovery of a High Affinity, Orally Bioavailable Macrocyclic FXIa Inhibitor with Antithrombotic Activity in Preclinical Species. Journal of medicinal chemistry 63 (13) (2020)

Kumar B Pabbisetty.css-eqlu8i{font-size:small;padding-left:4px;}